14.37
price down icon5.92%   -0.66
after-market After Hours: 14.36 -0.010 -0.07%
loading
Surgery Partners Inc stock is traded at $14.37, with a volume of 2.09M. It is down -5.92% in the last 24 hours and down -11.57% over the past month. Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$15.03
Open:
$14.84
24h Volume:
2.09M
Relative Volume:
1.34
Market Cap:
$1.88B
Revenue:
$3.34B
Net Income/Loss:
$97.10M
P/E Ratio:
-24.15
EPS:
-0.595
Net Cash Flow:
$208.00M
1W Performance:
-11.35%
1M Performance:
-11.57%
6M Performance:
-9.36%
1Y Performance:
-37.98%
1-Day Range:
Value
$14.09
$14.99
1-Week Range:
Value
$14.10
$16.28
52-Week Range:
Value
$11.41
$24.10

Surgery Partners Inc Stock (SGRY) Company Profile

Name
Name
Surgery Partners Inc
Name
Phone
615-234-5900
Name
Address
340 SEVEN SPRINGS WAY, BRENTWOOD, TN
Name
Employee
16,000
Name
Next Earnings Date
2026-08-04
Name
Latest SEC Filings
Name
SGRY's Discussions on Twitter

Compare SGRY vs HCA, THC, FMS, EHC, DVA

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
SGRY icon
SGRY
Surgery Partners Inc
14.37 1.97B 3.34B 97.10M 208.00M -0.595
HCA icon
HCA
Hca Healthcare Inc
404.92 87.61B 76.39B 7.81B 7.93B 29.08
THC icon
THC
Tenet Healthcare Corp
264.56 21.57B 21.46B 2.65B 3.35B 19.23
FMS icon
FMS
Fresenius Medical Care Ag Adr
23.51 12.65B 22.44B 1.35B 2.03B 1.9002
EHC icon
EHC
Encompass Health Corp
121.98 12.19B 6.07B 793.80M 464.40M 5.9914
DVA icon
DVA
Davita Inc
176.70 11.49B 13.84B 1.10B 1.49B 10.42

Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-18-25 Resumed JP Morgan Neutral
Jul-28-25 Resumed BofA Securities Buy
Dec-16-24 Initiated BofA Securities Buy
Oct-14-24 Initiated UBS Buy
Oct-11-24 Initiated KeyBanc Capital Markets Sector Weight
Jun-28-24 Initiated Macquarie Outperform
Mar-06-24 Initiated Barclays Equal Weight
Nov-14-23 Upgrade TD Cowen Market Perform → Outperform
Jun-02-23 Upgrade BofA Securities Neutral → Buy
May-12-23 Initiated Mizuho Buy
Apr-21-23 Initiated Cantor Fitzgerald Overweight
Nov-23-22 Reiterated RBC Capital Mkts Outperform
Jun-15-22 Downgrade BofA Securities Buy → Neutral
Jan-10-22 Resumed Citigroup Buy
Nov-30-21 Initiated Barclays Overweight
Nov-29-21 Upgrade Stifel Hold → Buy
Nov-01-21 Initiated JP Morgan Neutral
Oct-18-21 Initiated SVB Leerink Outperform
Sep-10-21 Initiated Cowen Market Perform
Jun-23-21 Resumed Stifel Hold
Sep-17-20 Reiterated The Benchmark Company Buy
Apr-27-20 Upgrade The Benchmark Company Hold → Buy
Mar-03-20 Downgrade The Benchmark Company Buy → Hold
Jan-14-20 Reiterated The Benchmark Company Buy
Nov-16-18 Initiated UBS Neutral
Sep-18-18 Upgrade BofA/Merrill Neutral → Buy
Jun-28-18 Upgrade Stifel Sell → Hold
Jan-30-18 Reiterated The Benchmark Company Buy
Nov-01-17 Downgrade BofA/Merrill Buy → Neutral
Aug-09-17 Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Aug-09-17 Downgrade Raymond James Strong Buy → Mkt Perform
Aug-09-17 Downgrade Stifel Hold → Sell
Apr-24-17 Reiterated Stifel Hold
Mar-10-17 Downgrade Stifel Buy → Hold
Jan-31-17 Initiated The Benchmark Company Buy
Jun-10-16 Initiated KeyBanc Capital Mkts Overweight
Mar-14-16 Reiterated RBC Capital Mkts Outperform
Oct-27-15 Initiated Stifel Buy
Oct-26-15 Initiated RBC Capital Mkts Outperform
Oct-26-15 Initiated Raymond James Strong Buy
View All

Surgery Partners Inc Stock (SGRY) Latest News

pulisher
09:35 AM

Does Surgery Partners’ (SGRY) Slower M&A Pace Clarify or Complicate Its ASC-Focused Strategy? - simplywall.st

09:35 AM
pulisher
02:30 AM

The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call - Yahoo Finance

02:30 AM
pulisher
Aug 15, 2026

Surgery Partners (SGRY) Reaffirmed Guidance On Revenue Growth, Is It Still A Bargain? - Sahm

Aug 15, 2026
pulisher
Aug 15, 2026

Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY) - Yahoo Finance

Aug 15, 2026
pulisher
Aug 14, 2026

Surgery Partners Inc. (SGRY) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks

Aug 14, 2026
pulisher
Aug 14, 2026

King Street Capital discloses 4.6% Surgery Partners (SGRY) holding in Schedule 13G - Stock Titan

Aug 14, 2026
pulisher
Aug 12, 2026

Why (SGRY) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Aug 12, 2026
pulisher
Aug 12, 2026

Surgery Partners Inc (1SP.DU) Recent Insider Transactions - Yahoo! Finance Canada

Aug 12, 2026
pulisher
Aug 12, 2026

TD Cowen Initiates Surgery Partners(SGRY.US) With Buy Rating, Announces Target Price $19 - Moomoo

Aug 12, 2026
pulisher
Aug 12, 2026

Surgery Partners (NASDAQ:SGRY) Downgraded by Zacks Research to Hold - MarketBeat

Aug 12, 2026
pulisher
Aug 12, 2026

Surgery Partners (SGRY) Stock Drops As Idaho Falls Sale Reshapes Debt Story - Sahm

Aug 12, 2026
pulisher
Aug 12, 2026

Surgery Partners Inc (1SP.DU) insider ownership and holdings - Yahoo Finance UK

Aug 12, 2026
pulisher
Aug 11, 2026

Is Surgery Partners Inc (SGRY) a Bargain After 5.8% Drop? GF Val - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

Surgery Partners beats Q2 revenue and EPS estimates, with strong growth and positive outlook. - Pluang

Aug 11, 2026
pulisher
Aug 11, 2026

SGRY Maintained by TD Cowen -- Price Target Raised to $19.00 - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight By Investing.com - Investing.com Nigeria

Aug 11, 2026
pulisher
Aug 11, 2026

SGRY Maintained by RBC Capital -- Price Target Lowered to $19.00 - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

Cantor Fitzgerald reiterates Surgery Partners stock rating at Overweight - Investing.com

Aug 11, 2026
pulisher
Aug 11, 2026

Benchmark reiterates Buy rating on Surgery Partners stock at $24 By Investing.com - Investing.com South Africa

Aug 11, 2026
pulisher
Aug 11, 2026

Benchmark reiterates Buy rating on Surgery Partners stock at $24 - Investing.com

Aug 11, 2026
pulisher
Aug 11, 2026

SGRY Reiterated by Cantor Fitzgerald -- Price Target Maintained at $18 - GuruFocus

Aug 11, 2026
pulisher
Aug 11, 2026

Surgery Partners (NASDAQ:SGRY) Given Overweight Rating at Cantor Fitzgerald - MarketBeat

Aug 11, 2026
pulisher
Aug 11, 2026

Surgery Partners (SGRY) Q2 Earnings: What To Expect - Yahoo Finance

Aug 11, 2026
pulisher
Aug 11, 2026

RBC Capital Adjusts Price Target on Surgery Partners to $19 From $20, Keeps Outperform Rating - marketscreener.com

Aug 11, 2026
pulisher
Aug 11, 2026

Surgery Partners, Inc. (SGRY) Investor Outlook: Navigating a 16.84% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Aug 11, 2026
pulisher
Aug 11, 2026

Surgery Partners Q2 2026 slides show 5% revenue growth, Idaho exit - Investing.com Canada

Aug 11, 2026
pulisher
Aug 11, 2026

SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift - The Globe and Mail

Aug 11, 2026
pulisher
Aug 10, 2026

Surgery Partners, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:SGRY) 2026-08-10 - Seeking Alpha

Aug 10, 2026
pulisher
Aug 10, 2026

Why Surgery Partners (NASDAQ:SGRY) Draws Healthcare Attention Monday? - Kalkine Media

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners (NASDAQ: SGRY) posts Q2 2026 loss and plans $795M hospital sale - Stock Titan

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners Crushes Q2 2026 Profit Estimates by 66.7% - AlphaStreet

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners: Q2 Earnings Snapshot - AOL.com

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners Releases Q2 2026 Financial Results - AlphaStreet

Aug 10, 2026
pulisher
Aug 10, 2026

SGRY Looks 42.7% Undervalued on GF Value™ Despite Profit Challen - GuruFocus

Aug 10, 2026
pulisher
Aug 10, 2026

Earnings call transcript: Surgery Partners misses Q2 2026 EPS, revenue beats - Investing.com Nigeria

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners Q2 Earnings Call Highlights - MarketBeat

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners (NASDAQ:SGRY) Shares Gap Up After Better-Than-Expected Earnings - marketbeat.com

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners shares edge lower despite Q2 revenue beat - Yahoo Finance

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners Announces Q2 and H1 2026 Financial Results with Investor Call - Kalkine Media

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners Inc earnings missed by $0.18, revenue topped estimates - Investing.com Canada

Aug 10, 2026
pulisher
Aug 10, 2026

Transcript : Surgery Partners, Inc., Q2 2026 Earnings Call, Aug 10, 2026 - marketscreener.com

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners beats revenue but misses on earnings By Investing.com - Investing.com Canada

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners' Q2 Earnings Decline, Revenue Rises - marketscreener.com

Aug 10, 2026
pulisher
Aug 10, 2026

Is Surgery Partners Inc (SGRY) a Value Trap? Q2 EPS at -$0.15 on $848.9 Million Revenue; GF Score: 57/100 - GuruFocus

Aug 10, 2026
pulisher
Aug 10, 2026

Q2 2026 Surgery Partners Inc Earnings Call Transcript - GuruFocus

Aug 10, 2026
pulisher
Aug 10, 2026

SGRY Looks 42.1% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners beats revenue but misses on earnings - Investing.com

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners (NASDAQ:SGRY) Posts Quarterly Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat

Aug 10, 2026
pulisher
Aug 10, 2026

Surgery Partners Reports Second Quarter 2026 Results, Reaffirms Full-Year Outlook - Quiver Quantitative

Aug 10, 2026

Surgery Partners Inc Stock (SGRY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Surgery Partners Inc Stock (SGRY) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Brittenham Marissa
Chief Strategy Officer
Mar 13 '26
Sale
12.54
3,657
45,859
94,196
Doherty David T
Chief Financial Officer
Mar 16 '26
Sale
12.50
8,867
110,838
221,679
Evans Jason Eric
Chief Executive Officer
Mar 16 '26
Sale
12.47
20,400
254,388
920,386
Baldock Jennifer
Chief Admin & Dev Officer
Mar 12 '26
Sale
13.17
5,798
76,360
326,474
$12.54
price up icon 0.93%
CHE CHE
$524.47
price down icon 1.87%
$44.36
price down icon 0.12%
UHS UHS
$171.12
price up icon 0.46%
$181.53
price down icon 0.09%
DVA DVA
$176.55
price down icon 1.96%
Cap:     |  Volume (24h):